Literature DB >> 12926160

Tenascin-C expression and its prognostic significance in oral and pharyngeal squamous cell carcinoma.

Timo Atula1, Johan Hedström, Patrik Finne, Ilmo Leivo, Mari Markkanen-Leppänen, Caj Haglund.   

Abstract

BACKGROUND: Tenascin-C (Tn-C) is an extracellular matrix protein with growth-, invasion- and angiogenesis-promoting activities. It is up-regulated in tumorigenesis and has been suggested to correlate with prognosis in various carcinomas, but its significance in squamous cell carcinoma of the head and neck remains unknown. The purpose of this study was to examine the prognostic significance of Tn-C expression in oral and pharyngeal squamous cell carcinomas. PATIENTS AND METHODS: Tn-C expression was determined by immunohistochemistry in 65 consecutive tumors from patients with primary oral and pharyngeal squamous cell carcinoma. Based on staining intensity, both the stroma and invasion border were separately classified into two groups and the results correlated with overall survival (OS) and disease-free survival (DFS).
RESULTS: The tumor stroma showed strong Tn-C expression in 56 (86%) samples, and weak Tn-C expression in 9 (14%). At the invasion border, Tn-C expression was strong in 38 (58%) samples and weak in 27 (42%). Tn-C expression was not a statistically significant predictor of survival and there was no correlation between Tn-C expression and tumor or patient characteristics.
CONCLUSION: Tn-C protein was overexpressed in the majority of our oral and pharyngeal squamous cell carcinoma samples. The presence of TnC did not appear to predict for OS or DFS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12926160

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and beta1 integrin.

Authors:  Adriane S Siqueira; Letícia N Gama-de-Souza; Maria Vanda C Arnaud; João J V Pinheiro; Ruy G Jaeger
Journal:  Tumour Biol       Date:  2009-12-09

2.  Tenascin-C in primary Merkel cell carcinoma.

Authors:  V Koljonen; T Jahkola; E Tukiainen; G Granroth; C Haglund; T Böhling
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

3.  Tenascin C expression is upregulated in pancreatic cancer and correlates with differentiation.

Authors:  A Juuti; S Nordling; J Louhimo; J Lundin; C Haglund
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

Review 4.  Tenascin-C and carcinoma cell invasion in oral and urinary bladder cancer.

Authors:  Alexander Berndt; Petra Richter; Hartwig Kosmehl; Marcus Franz
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

5.  Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4.

Authors:  Yohei Saito; Toshiyuki Owaki; Takuya Matsunaga; Mizue Saze; Shogo Miura; Mao Maeda; Mayu Eguchi; Rika Tanaka; Junichi Taira; Hiroaki Kodama; Sumio Goto; Yoshiroh Niitsu; Hiroshi Terada; Fumio Fukai
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

6.  Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer.

Authors:  A Brunner; C Mayerl; A Tzankov; I Verdorfer; I Tschörner; H Rogatsch; G Mikuz
Journal:  J Clin Pathol       Date:  2004-09       Impact factor: 3.411

Review 7.  Advances in tenascin-C biology.

Authors:  Kim S Midwood; Thomas Hussenet; Benoit Langlois; Gertraud Orend
Journal:  Cell Mol Life Sci       Date:  2011-08-05       Impact factor: 9.261

8.  Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation.

Authors:  Takuya Iyoda; Fumio Fukai
Journal:  Int J Cell Biol       Date:  2011-12-19

9.  Tenascin-C serum levels and its prognostic power in non-small cell lung cancer.

Authors:  Florian Gebauer; Suyin Gelis; Hilke Zander; Karl-Frederick Meyer; Gerrit Wolters-Eisfeld; Jakob R Izbicki; Maximilian Bockhorn; Michael Tachezy
Journal:  Oncotarget       Date:  2016-04-12

Review 10.  Tenascin-C: Form versus function.

Authors:  Sean P Giblin; Kim S Midwood
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.